Interestingly, some of the genes identified in symptomatic patients, including PPT2, DNTTIP2, IQCG, and PRDM16, had also been reported earlier in GWAS or transcriptomic analyses in patients with COPD [27], highlighting their potential significance for COPD predisposition. This evidence concerns the gene DNTTIP2 and chronic obstructive pulmonary disease.